Blood Test Predicts Immunotherapy Response - Summary - MDSpire

Blood Test Predicts Immunotherapy Response

  • May 18, 2026

Share

Objective:

To develop a machine-learning approach for predicting immunotherapy response in melanoma using blood-derived DNA.

Key Findings:
  • Identified nine conserved ecotypes linked to tumor biology and survival outcomes.
  • High levels of inflammatory ecotypes SE7 and SE8 correlated with durable benefit and longer survival post-therapy.
  • Ecotype SE4, associated with wound-healing, linked to resistance and poorer survival.
  • cfDNA-based approach outperformed established biomarkers like tumor mutational burden and PD-L1 expression.
Interpretation:

The study suggests that spatial ecotypes provide broader biological insights into tumor microenvironments, enhancing the predictive power for immunotherapy responses.

Limitations:
  • Findings require validation in larger prospective cohorts.
  • Potential challenges in standardizing cfDNA analysis across different laboratories.
Conclusion:

This research indicates a promising future for liquid biopsy in oncology, enabling noninvasive monitoring of tumor microenvironments and improving patient stratification and treatment monitoring.

Original Source(s)

Related Content